Predicting the severity of Duchenne muscular dystrophy: implications for treatment

Neurology. 2011 Jan 18;76(3):208-9. doi: 10.1212/WNL.0b013e3182074c0e. Epub 2010 Dec 22.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Animals
  • Disease Progression
  • Humans
  • Mice
  • Muscular Dystrophy, Duchenne / drug therapy*
  • Muscular Dystrophy, Duchenne / genetics*
  • Muscular Dystrophy, Duchenne / metabolism
  • Osteopontin / genetics*
  • Polymorphism, Single Nucleotide
  • Predictive Value of Tests
  • Research Design
  • Severity of Illness Index

Substances

  • Adrenal Cortex Hormones
  • SPP1 protein, human
  • Osteopontin